Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Key Points

• Advanced Medical Isotope Corporation (OTCMKTS:RDGL) experienced a dramatic increase in short interest of 4,877.8% in July, rising from 900 shares to a total of 44,800 shares by July 15th.
• The stock's trading performance showed 926,879 shares exchanged on Friday, with a current price of $0.13, while its 12-month range is between $0.06 and $0.18.
• Advanced Medical Isotope is associated with Vivos Inc, which develops brachytherapy devices for cancer treatment, focusing on innovative technologies like the RadioGel device.

Advanced Medical Isotope Corporation (OTCMKTS:RDGL - Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 44,800 shares, anincreaseof4,877.8% from the June 30th total of 900 shares. Based on an average trading volume of 2,338,200 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 2,338,200 shares, the short-interest ratio is presently 0.0 days.

Advanced Medical Isotope Trading Up 11.5%

OTCMKTS RDGL traded up $0.01 on Tuesday, hitting $0.12. 439,219 shares of the stock were exchanged, compared to its average volume of 988,329. Advanced Medical Isotope has a 52-week low of $0.06 and a 52-week high of $0.18. The company's 50-day moving average price is $0.13 and its two-hundred day moving average price is $0.12.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.